ETrade Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $340K | Buy |
2,418
+1,074
| +80% | +$151K | 0.01% | 680 |
|
|
2020
Q2 | $215K | Sell |
1,344
-732
| -35% | -$117K | ﹤0.01% | 758 |
|
|
2020
Q1 | $203K | Sell |
2,076
-1,284
| -38% | -$126K | 0.01% | 687 |
|
|
2019
Q4 | $434K | Sell |
3,360
-199
| -6% | -$25.7K | 0.01% | 590 |
|
|
2019
Q3 | $268K | Buy |
3,559
+452
| +15% | +$34K | 0.01% | 710 |
|
|
2019
Q2 | $472K | Buy |
3,107
+153
| +5% | +$23.2K | 0.01% | 579 |
|
|
2019
Q1 | $352K | Sell |
2,954
-1,321
| -31% | -$157K | 0.01% | 636 |
|
|
2018
Q4 | $467K | Sell |
4,275
-238
| -5% | -$26K | 0.02% | 502 |
|
|
2018
Q3 | $729K | Buy |
4,513
+76
| +2% | +$12.3K | 0.02% | 462 |
|
|
2018
Q2 | $586K | Buy |
4,437
+474
| +12% | +$62.6K | 0.02% | 493 |
|
|
2018
Q1 | $294K | Sell |
3,963
-471
| -11% | -$34.9K | 0.01% | 631 |
|
|
2017
Q4 | $247K | Buy |
+4,434
| New | +$247K | 0.01% | 667 |
|